Detalhe da pesquisa
1.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042063
2.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841909
3.
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
Eur J Cancer
; 162: 138-147, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995900
4.
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
Ther Adv Med Oncol
; 12: 1758835920975356, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33329760
5.
[Recurrence of upper aerodigestive tract tumors]. / Les récidives des tumeurs des voies aérodigestives supérieures.
Bull Cancer
; 101(5): 511-20, 2014 May 01.
Artigo
em Francês
| MEDLINE | ID: mdl-24886903
6.
Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients.
Cancer Chemother Pharmacol
; 74(5): 1057-64, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25217392
7.
Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials.
Per Med
; 11(5): 545-558, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29758779
8.
Cyclophosphamide induces differentiation of Th17 cells in cancer patients.
Cancer Res
; 71(3): 661-5, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148486
9.
An inhibitor of cyclin-dependent kinases suppresses TLR signaling and increases the susceptibility of cancer patients to herpesviridae.
Cell Cycle
; 10(1): 118-26, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21200142
10.
Critical evaluation of disease stabilization as a measure of activity of systemic therapy: lessons from trials with arms in which patients do not receive active treatment.
J Clin Oncol
; 32(3): 260-3, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297942